Philip Comp to Arthroplasty, Replacement, Hip
This is a "connection" page, showing publications Philip Comp has written about Arthroplasty, Replacement, Hip.
Connection Strength
0.397
-
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group. J Bone Joint Surg Am. 2001 Mar; 83(3):336-45.
Score: 0.182
-
A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement: The Danaparoid Hip Arthroplasty Investigators Group. Orthopedics. 1998 Oct; 21(10):1123-8.
Score: 0.154
-
Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost. 2005 May; 3(5):962-8.
Score: 0.061